Re-definition of claudin-low as a breast cancer phenotype
C. Fougner, H. Bergholtz, J. H. Norum, T. Sorlie
This study re-defines claudin-low as a complex breast cancer phenotype by analyzing genomic, transcriptomic, and clinical features, revealing its heterogeneity and distinct characteristics.
bioRxiv · Sep 9, 2019Cancer Biology